Trial intelligence / Profile preview

Pharmacokinetic evaluation of switching from intravenous to enteral moxifloxacin in ICU patients

2006-006334-18Phase 2Completed

Sponsor
Ghent University Hospital
Start
Mar 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of moxifloxacin in bacterial disease, sponsored by Ghent University Hospital. Started Mar 2007; status: completed.

02

Drugs

moxifloxacin
03

Conditions

bacterial disease

Beyond the preview

Go deeper on 2006-006334-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006334-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call